|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Investments at fair value: | ||||||||||||||||||
| Investments at fair value: | ||||||||||||||||||
| Companies less than 5% owned | ||||||||||||||||||
| Companies 5% to 25% owned | ||||||||||||||||||
| Companies more than 25% owned | ||||||||||||||||||
| Total investments at fair value: | ||||||||||||||||||
| Cash | ||||||||||||||||||
| Cash equivalents (cost: $457,918 and $348,585, respectively) | ||||||||||||||||||
| Dividends receivable | ||||||||||||||||||
| Interest receivable | ||||||||||||||||||
| Receivable for investments sold | ||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Liabilities | ||||||||||||||||||
| Debt ($1,111,875 and $1,154,436 face amounts, respectively, reported net of unamortized debt issuance costs of $5,695 and $8,082, respectively. See note 7) | ||||||||||||||||||
| Payable for investments and cash equivalents purchased | ||||||||||||||||||
| Distributions payable | ||||||||||||||||||
| Management fee payable (see note 3) | ||||||||||||||||||
| Performance-based incentive fee payable (see note 3) | ||||||||||||||||||
| Interest payable (see note 7) | ||||||||||||||||||
| Administrative services payable (see note 3) | ||||||||||||||||||
| Other liabilities and accrued expenses | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Net Assets | ||||||||||||||||||
| Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,554,634 and 54,554,634 shares issued and outstanding, respectively | ||||||||||||||||||
| Paid-in capital in excess of par | ||||||||||||||||||
| Accumulated distributable net loss | ||||||||||||||||||
| Total net assets | ||||||||||||||||||
| Net Asset Value Per Share |
Loading...